Horizon Scanning


With Horizon Scanning, Amgros creates a comprehensive overview of new medicines and indication extensions expected to be marketed in Denmark within the next two to three years. This overview enables the Danish Medicines Council to plan its work well in advance. At the same time, it provides Amgros with a stronger basis for preparing upcoming price negotiations with suppliers and organising tendering procedures. We also prepare financial estimates that give the regions a solid foundation for planning their medicine budgets. These estimates take into account both new, often more expensive treatments and potential savings when lower-cost alternatives enter the market.

EXPECTATIONS FOR FUTURE CONSUMPTION
Our estimates and analyses support financial prioritisation in the healthcare system.

Danish Regions use the estimates in their annual negotiations with the Government on regional finances, and the individual regions use them when planning their budgets.

The estimates cover both increased costs associated with new medicines and savings from lower-cost alternatives.
METHOD AND SOURCES
We work systematically to create an overview of upcoming medicines and use several different sources.

Among other things, we collect data from the European Medicines Agency (EMA) and supplement this with knowledge from commercial databases and international newsletters.

In addition, we regularly hold pipeline meetings with pharmaceutical companies. These provide insight into the products they expect to introduce to the Danish market in the coming years.

We also participate in national and international conferences and networks. This helps ensure that we stay up to date and remain at the forefront of developments in the field.
!
We are open to dialogue
Horizon Scanning is always open to dialogue with interested stakeholders in the healthcare sector. You are very welcome to contact one of our specialists – both regarding general questions or specific data.

Read more

Horizon Scanning

Horizon Scanning overviews

Horizon Scanning prepares lists of new medicines, extensions of indication and other extensions undergoing evaluation by the EMA.

READ MORE
Horizon Scanning

Pipeline meetings

READ MORE
Horizon Scanning

Latest news

If you would like to receive news from Amgros directly in your inbox, sign up for our newsletter. You can choose between general news or the latest news from Horizon Scanning.

SIGN UP
Horizon Scanning

Find your way through EMA

Horizon Scanning draws, among other sources, on information from the European Medicines Agency (EMA). We continuously register and monitor pharmaceutical companies’ applications to the EMA. We communicate the collected information through the briefings and overviews that we publish on our website.

READ MORE